Nice job guys. PYC are becoming experts at bringing brilliant 'world leading' technology together and making it work.
from the ANN:
Sue Fletcher, PYC’s CSO: Our CPP-LNP delivery technology is an exciting development that we
expect will open the door to many additional nucleic acid drugs. We are particularly delighted
by this demonstration of the benefits of our collaborative approach to research and drug
development and thank Prof. Dan Peer for joining us on this journey
Ann: Creation of Novel Gene Therapy Delivery Technology, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |